Kotyark Industries has closed the trading window for its equity shares effective October 1, 2026. This closure precedes the declaration of un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

The restriction applies to all insiders covered under the company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities. Designated persons have been informed that they must not trade in the company's securities during this period.

Regulatory Compliance and Timeline

The decision was taken pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. The trading window will remain closed until 48 hours after the official announcement of the financial results.

Board Meeting Update

The company stated that the specific date for the Board Meeting to consider and declare these financial results will be intimated to the exchanges in due course. The filing was submitted to both the National Stock Exchange of India Limited and BSE Limited on September 28, 2026.

Kotyark Industries reported consolidated revenue of ₹91.98 crore for Q1FY27, an 11.5% increase from ₹82.46 crore in the same period last year. Profit before tax (PBT) grew 30.54% year-on-year to ₹7.47 crore, driven by higher volumes and cost discipline.

The biodiesel manufacturer attributed the growth to steady demand across oil marketing companies (OMCs) and industrial applications. Standalone profitability faced pressure due to international price differentials between fossil fuels and biofuels, though domestic consumption remained robust.

Financial Performance

Revenue rose to ₹91.98 crore in Q1FY27 from ₹82.46 crore in Q1FY26. EBITDA increased to ₹11.71 crore, expanding the margin slightly to 12.73% from 12.51%. Net profit reached ₹4.46 crore, compared to ₹4.09 crore in the prior-year quarter.

For FY26, total revenue stood at ₹314.87 crore against ₹288.10 crore in FY25. Full-year PAT was ₹19.36 crore, up from ₹14.53 crore.

Order Book & Capacity

The company disclosed an existing OMC order book of approximately ₹173.45 crore, with execution expected over current and upcoming quarters. An additional ₹60 crore in orders from other parties and a pipeline of ₹15 crore under discussion provide further visibility.

Kotyark operates manufacturing facilities in Sirohi, Rajasthan, and Anand, Gujarat, with a combined annual biodiesel capacity of 4,80,000 kilolitres. Current utilization stands at 7-8%, with management targeting 60-70% over the medium term through improved OMC participation and industrial demand.

What the Numbers Show

Revenue concentration is shifting away from OMCs. In FY25, OMCs contributed 90% of revenue, but this share dropped to 70% in FY26 as bulk buyers and retail channels expanded to 30%. This diversification reduces dependency on government tender cycles while leveraging the company’s flexible multi-feedstock platform.

Strategic Outlook

Management aims for a 25-30% revenue CAGR and 18-22% EBITDA margins over the next three years. Key priorities include increasing capacity utilization, strengthening feedstock sourcing, and expanding value-added opportunities such as glycerin production. The company also highlighted potential carbon credit monetization, having earned 57,874 credits previously.